Results
1870
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
1870 companies
Darwin
Market Cap: €96.0m
Operates as a biotechnology company.
7V0
€8.00
7D
0%
1Y
26.0%
Curiox Biosystems
Market Cap: ₩1.1t
Manufactures and sells medical appliances and instruments in South Korea.
A445680
₩62,900.00
7D
10.4%
1Y
228.8%
Guizhou Bailing Group Pharmaceutical
Market Cap: CN¥7.4b
Guizhou Bailing Group Pharmaceutical Co., Ltd.
002424
CN¥5.42
7D
-4.1%
1Y
51.0%
Kwang Dong Pharmaceutical
Market Cap: ₩231.0b
Operates as a human healthcare provider in South Korea.
A009290
₩5,880.00
7D
-0.5%
1Y
-0.5%
Lavipharm
Market Cap: €138.2m
Engages in the research, development, manufacture, import, marketing, sale, and wholesale of pharmaceutical, cosmetics, and healthcare products to physicians and pharmacists in Greece and internationally.
LAVI
€0.84
7D
-0.9%
1Y
2.2%
Biocytogen Pharmaceuticals (Beijing)
Market Cap: HK$11.4b
A biotechnology company, engages in the research and development of novel antibody-based drugs in the People’s Republic of China, the United States, and internationally.
2315
HK$28.60
7D
4.0%
1Y
309.2%
PCI Biotech Holding
Market Cap: NOK 12.2m
A biopharmaceutical company, focuses on the development of technologies and novel therapies through its photochemical technology platform.
PCIB
NOK 0.32
7D
-5.9%
1Y
-82.6%
BioDlink International
Market Cap: HK$1.8b
An investment holding company, engages in the research and development, manufacturing, and marketing of anti-tumor drugs in Mainland China and internationally.
1875
HK$2.29
7D
4.6%
1Y
17.4%
H. Lundbeck
Market Cap: DKK 43.1b
Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.
HLUN B
DKK 44.48
7D
-1.2%
1Y
0.8%
Zhejiang Tianyu Pharmaceutical
Market Cap: CN¥8.8b
Engages in the research, development, manufacture, and sale of pharmaceutical intermediates and APIs in China and internationally.
300702
CN¥25.69
7D
-2.8%
1Y
66.4%
Ascentage Pharma Group International
Market Cap: HK$26.7b
A clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China.
6855
HK$72.70
7D
-3.4%
1Y
80.8%
Hikal
Market Cap: ₹31.4b
Manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, biotechnology, life sciences, animal health, crop protection, and specialty chemicals indusries.
524735
₹254.80
7D
-5.3%
1Y
-31.4%
Gansu Longshenrongfa Pharmaceutical IndustryLTD
Market Cap: CN¥2.9b
Researches, develops, produces, and sells Chinese patent medicines, health food, and APIs in China and internationally.
300534
CN¥9.65
7D
-0.3%
1Y
20.6%
Naturalendo Tech
Market Cap: ₩83.7b
Engages in the research, development, manufacture, and sale of physical chemistry and biology, biological agents, food additives, and health functional food in South Korea.
A168330
₩2,650.00
7D
-7.8%
1Y
54.6%
Imexpharm
Market Cap: ₫8.2t
Manufactures, processes, trades, imports, and exports pharmaceutical products in Vietnam and internationally.
IMP
₫53,000.00
7D
-0.7%
1Y
5.4%
Liven Pharmaceuticals
Market Cap: PK₨6.2b
Manufactures and markets pharmaceutical products in Pakistan.
LIVEN
PK₨66.61
7D
-3.4%
1Y
134.8%
ROKIT Healthcare
Market Cap: ₩331.4b
A biotechnology company, provides hyper-personalized organ regenerative healthcare solutions in South Korea.
A376900
₩21,500.00
7D
20.8%
1Y
n/a
Vaishali Pharma
Market Cap: ₹1.5b
Engages in the pharmaceutical business in India and internationally.
VAISHALI
₹11.81
7D
-2.5%
1Y
-39.7%
Pharma Foods International
Market Cap: JP¥24.5b
Engages in the development and sale of functional food ingredients in Japan.
2929
JP¥850.00
7D
3.2%
1Y
-7.8%
Shanghai Haoyuan Chemexpress
Market Cap: CN¥16.8b
Researches, develops, and manufactures pharmaceutical intermediates and small molecule drugs.
688131
CN¥79.22
7D
7.4%
1Y
183.5%
Guizhou Sanli PharmaceuticalLtd
Market Cap: CN¥5.1b
GuiZhou SanLi Pharmaceutical Co.,LTD. engages in the research and development, production, and marketing of pharmaceutical products.
603439
CN¥12.65
7D
-3.1%
1Y
-9.4%
XtalPi Holdings
Market Cap: HK$52.3b
An investment holding company, engages in the provision of robotics and drug discovery solutions in Mainland China, the United States, and internationally.
2228
HK$12.16
7D
15.3%
1Y
-5.0%
Pharmedic Pharmaceutical Medicinal
Market Cap: ₫1.0t
Engages in the manufacture and trade of pharmaceutical products, medicinal materials, cosmetics, medical supplies, and other products in Vietnam.
PMC
₫110,000.00
7D
0%
1Y
26.7%
PhoenixBio
Market Cap: JP¥1.6b
Provides contract study services for drug discovery and development primarily in Japan.
6190
JP¥407.00
7D
-1.9%
1Y
-8.1%
Onyx Biotec
Market Cap: ₹830.4m
Develops, manufactures, and distributes generic and proprietary pharmaceutical products in India and internationally.
ONYX
₹44.95
7D
-0.7%
1Y
n/a
Aarey Drugs & Pharmaceuticals
Market Cap: ₹2.0b
Manufactures and sells active pharmaceutical ingredients, intermediates, and specialty chemicals for various industrial applications in India.
524412
₹78.72
7D
4.5%
1Y
11.0%
Beijing Luzhu Biotechnology
Market Cap: HK$5.0b
A biotechnology company, focuses on the research and development, production, and sale of human vaccines and therapeutic biologics to prevent and control infectious diseases, and treat cancer and autoimmune diseases in Mainland China.
2480
HK$25.20
7D
1.3%
1Y
5.2%
Dizal (Jiangsu) Pharmaceutical
Market Cap: CN¥32.4b
Dizal (Jiangsu) Pharmaceutical Co., Ltd. discovers, develops, and commercializes medicines in the areas of cancer and immunological diseases.
688192
CN¥70.42
7D
0.6%
1Y
86.2%
Takeda Pharmaceutical
Market Cap: JP¥6.9t
Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.
4502
JP¥4,438.00
7D
-0.9%
1Y
6.6%
Oxford BioDynamics
Market Cap: UK£9.3m
Operates as a biotechnology company that discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom.
OBD
UK£0.0047
7D
0%
1Y
-85.1%
Curasight
Market Cap: DKK 218.3m
Develops therapeutic and diagnostic solutions for the treatment of cancer.
CURAS
DKK 4.84
7D
1.0%
1Y
-52.1%
Cellectis
Market Cap: €214.4m
A clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications.
ALCLS
€2.99
7D
-2.8%
1Y
52.8%
Genus
Market Cap: UK£1.5b
Operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia.
GNS
UK£22.90
7D
-6.5%
1Y
13.6%
Tryptamine Therapeutics
Market Cap: AU$61.9m
A clinical-stage pharmaceutical development company, focuses on developing formulations for the administration of psilocin in combination with psychotherapy to treat diseases with unmet medical needs in Australia, Canada, Switzerland, and the United States.
TYP
AU$0.043
7D
34.4%
1Y
138.9%
Xspray Pharma
Market Cap: SEK 2.5b
A pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden.
XSPRAY
SEK 57.00
7D
8.4%
1Y
12.2%
Nidhogg Resources Holding
Market Cap: SEK 13.8m
Operates in the natural resources sector primarily in Sweden.
NIDHOG
SEK 1.58
7D
-1.3%
1Y
-77.4%